Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.
|Numero di pagine||4|
|Rivista||Aging clinical and experimental research|
|Stato di pubblicazione||Published - 2006|
All Science Journal Classification (ASJC) codes
- Geriatrics and Gerontology